Minimally Invasive Treatment of Lung Cancer
Market Analysis and Insights: Global Minimally Invasive Treatment of Lung Cancer Market Read More
Bronchoscopy technology has advanced with the development of robotic-assisted bronchoscopy (also known as robotic bronchoscopy). This technology allows physicians to move the flexible bronchoscopy tube with precision using a controller. The tube used in robotic bronchoscopy is typically smaller than those that may be used in traditional bronchoscopy. The physician uses the controller to move the small tube in precise ways which allows the physician to reach parts of the lung that may have been challenging to access with traditional bronchoscopy techniques. While the physician is controlling the robotic system, a 3-D map of the patient’s lung is shown on a computer screen. This allows the physician to see exactly where the tube is in the person’s lung and where it needs to go, and guides the physician to get to the nodule, much like GPS in a car.
Due to the COVID-19 pandemic, the global Robotic-assisted Bronchoscopy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Robotic-assisted Bronchoscopy market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Robotic-assisted Bronchoscopy landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Therapeutic accounting for % of the Robotic-assisted Bronchoscopy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Robotic-assisted Bronchoscopy include Intuitive Surgica and Auris Health etc. In terms of revenue, the global 3 largest players have a % market share of Robotic-assisted Bronchoscopy in 2021.
This report focuses on Robotic-assisted Bronchoscopy volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Robotic-assisted Bronchoscopy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Robotic-assisted Bronchoscopy Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Therapeutic
Diagnostic
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Intuitive Surgica
Auris Health
Market Analysis and Insights: Global Minimally Invasive Treatment of Lung Cancer Market Read More
Market Analysis and Insights: Global Lung Tumor Ablation Market
Lung tumor ablation ... Read More
Market Analysis and Insights: Global Lung Tumor Embolization Market
Transcatheter b ... Read More
Smart patches are a kind of wearable sensor used in the medical industry. They are applied to a p ... Read More